Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2026-01-04 @ 3:01 AM
Study NCT ID:
NCT04402866
Status:
COMPLETED
Last Update Posted:
2022-03-17
First Post:
2020-05-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
TD-0903 for ALI Associated With COVID-19
Sponsor:
Theravance Biopharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0188
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None